nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Tocainide—SCN10A—breast cancer	0.00358	0.813	CrCbGaD
Prilocaine—Tocainide—ALB—breast cancer	0.000822	0.187	CrCbGaD
Prilocaine—Anaphylactic shock—Irinotecan—breast cancer	0.000571	0.000796	CcSEcCtD
Prilocaine—Oedema—Irinotecan—breast cancer	0.000571	0.000796	CcSEcCtD
Prilocaine—Feeling abnormal—Vinorelbine—breast cancer	0.000571	0.000795	CcSEcCtD
Prilocaine—Hypersensitivity—Goserelin—breast cancer	0.00057	0.000794	CcSEcCtD
Prilocaine—Asthenia—Melphalan—breast cancer	0.000569	0.000792	CcSEcCtD
Prilocaine—Pain—Thiotepa—breast cancer	0.000566	0.000788	CcSEcCtD
Prilocaine—Shock—Irinotecan—breast cancer	0.000562	0.000783	CcSEcCtD
Prilocaine—Shock—Mitoxantrone—breast cancer	0.000562	0.000783	CcSEcCtD
Prilocaine—Nervous system disorder—Irinotecan—breast cancer	0.00056	0.00078	CcSEcCtD
Prilocaine—Tension—Paclitaxel—breast cancer	0.00056	0.00078	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Epirubicin—breast cancer	0.00056	0.00078	CcSEcCtD
Prilocaine—Anaphylactic shock—Gemcitabine—breast cancer	0.000556	0.000775	CcSEcCtD
Prilocaine—Oedema—Gemcitabine—breast cancer	0.000556	0.000775	CcSEcCtD
Prilocaine—Cardiac failure—Epirubicin—breast cancer	0.000555	0.000773	CcSEcCtD
Prilocaine—Asthenia—Goserelin—breast cancer	0.000555	0.000773	CcSEcCtD
Prilocaine—Nervousness—Paclitaxel—breast cancer	0.000554	0.000772	CcSEcCtD
Prilocaine—Hypoaesthesia—Docetaxel—breast cancer	0.000553	0.00077	CcSEcCtD
Prilocaine—Hyperhidrosis—Irinotecan—breast cancer	0.000552	0.000769	CcSEcCtD
Prilocaine—Hyperhidrosis—Mitoxantrone—breast cancer	0.000552	0.000769	CcSEcCtD
Prilocaine—Confusional state—Fluorouracil—breast cancer	0.000552	0.000768	CcSEcCtD
Prilocaine—Dizziness—Vinblastine—breast cancer	0.000551	0.000768	CcSEcCtD
Prilocaine—Urticaria—Vinorelbine—breast cancer	0.00055	0.000766	CcSEcCtD
Prilocaine—Bradycardia—Capecitabine—breast cancer	0.000548	0.000763	CcSEcCtD
Prilocaine—Anaphylactic shock—Fluorouracil—breast cancer	0.000547	0.000762	CcSEcCtD
Prilocaine—Oedema—Fluorouracil—breast cancer	0.000547	0.000762	CcSEcCtD
Prilocaine—Nervous system disorder—Gemcitabine—breast cancer	0.000546	0.00076	CcSEcCtD
Prilocaine—Feeling abnormal—Thiotepa—breast cancer	0.000545	0.000759	CcSEcCtD
Prilocaine—Osteoarthritis—Epirubicin—breast cancer	0.000542	0.000755	CcSEcCtD
Prilocaine—Diplopia—Epirubicin—breast cancer	0.000542	0.000755	CcSEcCtD
Prilocaine—Nausea—Chlorambucil—breast cancer	0.00054	0.000752	CcSEcCtD
Prilocaine—Vision blurred—Paclitaxel—breast cancer	0.000538	0.000749	CcSEcCtD
Prilocaine—Hyperhidrosis—Gemcitabine—breast cancer	0.000538	0.000749	CcSEcCtD
Prilocaine—Nervous system disorder—Fluorouracil—breast cancer	0.000536	0.000747	CcSEcCtD
Prilocaine—Hypoaesthesia—Capecitabine—breast cancer	0.000535	0.000746	CcSEcCtD
Prilocaine—Dizziness—Tamoxifen—breast cancer	0.000535	0.000746	CcSEcCtD
Prilocaine—Tremor—Paclitaxel—breast cancer	0.000535	0.000745	CcSEcCtD
Prilocaine—Hypotension—Mitoxantrone—breast cancer	0.000534	0.000743	CcSEcCtD
Prilocaine—Hypotension—Irinotecan—breast cancer	0.000534	0.000743	CcSEcCtD
Prilocaine—Vomiting—Vinblastine—breast cancer	0.00053	0.000738	CcSEcCtD
Prilocaine—Anaemia—Paclitaxel—breast cancer	0.000527	0.000735	CcSEcCtD
Prilocaine—Urticaria—Thiotepa—breast cancer	0.000525	0.000732	CcSEcCtD
Prilocaine—Hypotension—Gemcitabine—breast cancer	0.00052	0.000724	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—CFL1—breast cancer	0.000519	0.00187	CbGpPWpGaD
Prilocaine—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000518	0.000722	CcSEcCtD
Prilocaine—Cardiac arrest—Epirubicin—breast cancer	0.000515	0.000718	CcSEcCtD
Prilocaine—Vomiting—Tamoxifen—breast cancer	0.000515	0.000717	CcSEcCtD
Prilocaine—Cardiac failure—Doxorubicin—breast cancer	0.000514	0.000716	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MED12—breast cancer	0.000513	0.00185	CbGpPWpGaD
Prilocaine—Paraesthesia—Irinotecan—breast cancer	0.000513	0.000714	CcSEcCtD
Prilocaine—Paraesthesia—Mitoxantrone—breast cancer	0.000513	0.000714	CcSEcCtD
Prilocaine—Syncope—Paclitaxel—breast cancer	0.000512	0.000713	CcSEcCtD
Prilocaine—Dizziness—Goserelin—breast cancer	0.000511	0.000712	CcSEcCtD
Prilocaine—Hypotension—Fluorouracil—breast cancer	0.000511	0.000712	CcSEcCtD
Prilocaine—Hypersensitivity—Vinorelbine—breast cancer	0.00051	0.000711	CcSEcCtD
Prilocaine—Somnolence—Mitoxantrone—breast cancer	0.000508	0.000707	CcSEcCtD
Prilocaine—Somnolence—Irinotecan—breast cancer	0.000508	0.000707	CcSEcCtD
Prilocaine—Vomiting—Melphalan—breast cancer	0.000504	0.000702	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—PAK1—breast cancer	0.000504	0.00181	CbGpPWpGaD
Prilocaine—Tinnitus—Capecitabine—breast cancer	0.000502	0.000699	CcSEcCtD
Prilocaine—Loss of consciousness—Paclitaxel—breast cancer	0.000502	0.000699	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—breast cancer	0.000501	0.000698	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—breast cancer	0.000501	0.000698	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—CFL1—breast cancer	0.0005	0.0018	CbGpPWpGaD
Prilocaine—Paraesthesia—Gemcitabine—breast cancer	0.0005	0.000696	CcSEcCtD
Prilocaine—Asthenia—Vinorelbine—breast cancer	0.000497	0.000692	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—HSP90AA1—breast cancer	0.000497	0.00179	CbGpPWpGaD
Prilocaine—Arrhythmia—Docetaxel—breast cancer	0.000496	0.000692	CcSEcCtD
Prilocaine—Nausea—Vinblastine—breast cancer	0.000495	0.000689	CcSEcCtD
Prilocaine—Somnolence—Gemcitabine—breast cancer	0.000495	0.000689	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MED12—breast cancer	0.000493	0.00177	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—CFL1—breast cancer	0.000493	0.00177	CbGpPWpGaD
Prilocaine—Hypertension—Paclitaxel—breast cancer	0.000493	0.000686	CcSEcCtD
Prilocaine—Vomiting—Goserelin—breast cancer	0.000492	0.000685	CcSEcCtD
Prilocaine—Paraesthesia—Fluorouracil—breast cancer	0.000491	0.000684	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA3—breast cancer	0.00049	0.00177	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—WNT1—breast cancer	0.00049	0.00177	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—SRC—breast cancer	0.000489	0.00176	CbGpPWpGaD
Prilocaine—Pain—Mitoxantrone—breast cancer	0.000488	0.00068	CcSEcCtD
Prilocaine—Pain—Irinotecan—breast cancer	0.000488	0.00068	CcSEcCtD
Prilocaine—Hypersensitivity—Thiotepa—breast cancer	0.000487	0.000679	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SLC2A2—breast cancer	0.000487	0.00175	CbGpPWpGaD
Prilocaine—Somnolence—Fluorouracil—breast cancer	0.000486	0.000677	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—PAK1—breast cancer	0.000486	0.00175	CbGpPWpGaD
Prilocaine—Anxiety—Paclitaxel—breast cancer	0.000484	0.000674	CcSEcCtD
Prilocaine—Nausea—Tamoxifen—breast cancer	0.000481	0.00067	CcSEcCtD
Prilocaine—Arrhythmia—Capecitabine—breast cancer	0.000481	0.00067	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—HSP90AA1—breast cancer	0.000477	0.00172	CbGpPWpGaD
Prilocaine—Cardiac arrest—Doxorubicin—breast cancer	0.000477	0.000664	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ADAM10—breast cancer	0.000476	0.00171	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HES1—breast cancer	0.000476	0.00171	CbGpPWpGaD
Prilocaine—Pain—Gemcitabine—breast cancer	0.000476	0.000663	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MED12—breast cancer	0.000475	0.00171	CbGpPWpGaD
Prilocaine—Asthenia—Thiotepa—breast cancer	0.000474	0.000661	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—WNT1—breast cancer	0.000471	0.0017	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCOA3—breast cancer	0.000471	0.0017	CbGpPWpGaD
Prilocaine—Nausea—Melphalan—breast cancer	0.000471	0.000656	CcSEcCtD
Prilocaine—Feeling abnormal—Irinotecan—breast cancer	0.000471	0.000656	CcSEcCtD
Prilocaine—Feeling abnormal—Mitoxantrone—breast cancer	0.000471	0.000656	CcSEcCtD
Prilocaine—Confusional state—Paclitaxel—breast cancer	0.00047	0.000654	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—SRC—breast cancer	0.000469	0.00169	CbGpPWpGaD
Prilocaine—Pain—Fluorouracil—breast cancer	0.000468	0.000652	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SLC2A2—breast cancer	0.000468	0.00168	CbGpPWpGaD
Prilocaine—Oedema—Paclitaxel—breast cancer	0.000466	0.000649	CcSEcCtD
Prilocaine—Anaphylactic shock—Paclitaxel—breast cancer	0.000466	0.000649	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—HSP90AA1—breast cancer	0.00046	0.00166	CbGpPWpGaD
Prilocaine—Nausea—Goserelin—breast cancer	0.000459	0.00064	CcSEcCtD
Prilocaine—Feeling abnormal—Gemcitabine—breast cancer	0.000458	0.000639	CcSEcCtD
Prilocaine—Shock—Paclitaxel—breast cancer	0.000458	0.000638	CcSEcCtD
Prilocaine—Dizziness—Vinorelbine—breast cancer	0.000458	0.000638	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—ADAM10—breast cancer	0.000458	0.00165	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—breast cancer	0.000457	0.00165	CbGpPWpGaD
Prilocaine—Nervous system disorder—Paclitaxel—breast cancer	0.000457	0.000636	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—WNT1—breast cancer	0.000454	0.00164	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NCOA3—breast cancer	0.000454	0.00164	CbGpPWpGaD
Prilocaine—Urticaria—Mitoxantrone—breast cancer	0.000454	0.000632	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—SRC—breast cancer	0.000453	0.00163	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SLC2A2—breast cancer	0.000451	0.00162	CbGpPWpGaD
Prilocaine—Feeling abnormal—Fluorouracil—breast cancer	0.000451	0.000628	CcSEcCtD
Prilocaine—Hyperhidrosis—Paclitaxel—breast cancer	0.00045	0.000627	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—MAPK3—breast cancer	0.00045	0.00162	CbGpPWpGaD
Prilocaine—Anaemia—Docetaxel—breast cancer	0.000447	0.000623	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—breast cancer	0.000446	0.000621	CcSEcCtD
Prilocaine—Vision blurred—Capecitabine—breast cancer	0.000441	0.000615	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ADAM10—breast cancer	0.000441	0.00159	CbGpPWpGaD
Prilocaine—Vomiting—Vinorelbine—breast cancer	0.00044	0.000613	CcSEcCtD
Prilocaine—Tremor—Capecitabine—breast cancer	0.000439	0.000611	CcSEcCtD
Prilocaine—Dizziness—Thiotepa—breast cancer	0.000437	0.000609	CcSEcCtD
Prilocaine—Hypotension—Paclitaxel—breast cancer	0.000435	0.000606	CcSEcCtD
Prilocaine—Urticaria—Fluorouracil—breast cancer	0.000435	0.000605	CcSEcCtD
Prilocaine—Syncope—Docetaxel—breast cancer	0.000434	0.000604	CcSEcCtD
Prilocaine—Anaemia—Capecitabine—breast cancer	0.000433	0.000603	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—MAPK3—breast cancer	0.000432	0.00156	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—ABL1—breast cancer	0.000431	0.00155	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—EGFR—breast cancer	0.000428	0.00154	CbGpPWpGaD
Prilocaine—Sweating—Methotrexate—breast cancer	0.000428	0.000596	CcSEcCtD
Prilocaine—Loss of consciousness—Docetaxel—breast cancer	0.000425	0.000592	CcSEcCtD
Prilocaine—Hypersensitivity—Irinotecan—breast cancer	0.000421	0.000586	CcSEcCtD
Prilocaine—Hypersensitivity—Mitoxantrone—breast cancer	0.000421	0.000586	CcSEcCtD
Prilocaine—Vomiting—Thiotepa—breast cancer	0.00042	0.000586	CcSEcCtD
Prilocaine—Syncope—Capecitabine—breast cancer	0.00042	0.000585	CcSEcCtD
Prilocaine—Paraesthesia—Paclitaxel—breast cancer	0.000418	0.000583	CcSEcCtD
Prilocaine—Hypertension—Docetaxel—breast cancer	0.000418	0.000582	CcSEcCtD
Prilocaine—Drowsiness—Epirubicin—breast cancer	0.000418	0.000582	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAPK3—breast cancer	0.000417	0.0015	CbGpPWpGaD
Prilocaine—Somnolence—Paclitaxel—breast cancer	0.000414	0.000577	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—ABL1—breast cancer	0.000414	0.00149	CbGpPWpGaD
Prilocaine—Loss of consciousness—Capecitabine—breast cancer	0.000412	0.000573	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—EGFR—breast cancer	0.000411	0.00148	CbGpPWpGaD
Prilocaine—Nausea—Vinorelbine—breast cancer	0.000411	0.000573	CcSEcCtD
Prilocaine—Asthenia—Irinotecan—breast cancer	0.00041	0.000571	CcSEcCtD
Prilocaine—Asthenia—Mitoxantrone—breast cancer	0.00041	0.000571	CcSEcCtD
Prilocaine—Neuropathy peripheral—Epirubicin—breast cancer	0.000409	0.00057	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA2—breast cancer	0.000409	0.00147	CbGpPWpGaD
Prilocaine—Hypertension—Capecitabine—breast cancer	0.000404	0.000563	CcSEcCtD
Prilocaine—Hypersensitivity—Fluorouracil—breast cancer	0.000403	0.000561	CcSEcCtD
Prilocaine—Sweating—Epirubicin—breast cancer	0.0004	0.000558	CcSEcCtD
Prilocaine—Asthenia—Gemcitabine—breast cancer	0.000399	0.000556	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ABL1—breast cancer	0.000399	0.00144	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—breast cancer	0.000399	0.00144	CbGpPWpGaD
Prilocaine—Pain—Paclitaxel—breast cancer	0.000398	0.000555	CcSEcCtD
Prilocaine—Confusional state—Docetaxel—breast cancer	0.000398	0.000555	CcSEcCtD
Prilocaine—Anxiety—Capecitabine—breast cancer	0.000397	0.000554	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—EGFR—breast cancer	0.000397	0.00143	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Docetaxel—breast cancer	0.000395	0.00055	CcSEcCtD
Prilocaine—Oedema—Docetaxel—breast cancer	0.000395	0.00055	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—NCOA2—breast cancer	0.000393	0.00142	CbGpPWpGaD
Prilocaine—Nausea—Thiotepa—breast cancer	0.000393	0.000547	CcSEcCtD
Prilocaine—Shock—Docetaxel—breast cancer	0.000388	0.000541	CcSEcCtD
Prilocaine—Nervous system disorder—Docetaxel—breast cancer	0.000387	0.000539	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—breast cancer	0.000386	0.000538	CcSEcCtD
Prilocaine—Confusional state—Capecitabine—breast cancer	0.000385	0.000537	CcSEcCtD
Prilocaine—Feeling abnormal—Paclitaxel—breast cancer	0.000384	0.000535	CcSEcCtD
Prilocaine—Oedema—Capecitabine—breast cancer	0.000382	0.000532	CcSEcCtD
Prilocaine—Bradycardia—Epirubicin—breast cancer	0.000382	0.000532	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA2—breast cancer	0.000379	0.00136	CbGpPWpGaD
Prilocaine—Neuropathy peripheral—Doxorubicin—breast cancer	0.000379	0.000528	CcSEcCtD
Prilocaine—Dizziness—Irinotecan—breast cancer	0.000378	0.000526	CcSEcCtD
Prilocaine—Shock—Capecitabine—breast cancer	0.000376	0.000524	CcSEcCtD
Prilocaine—Nervous system disorder—Capecitabine—breast cancer	0.000375	0.000522	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—PAK1—breast cancer	0.000374	0.00135	CbGpPWpGaD
Prilocaine—Tinnitus—Methotrexate—breast cancer	0.000373	0.00052	CcSEcCtD
Prilocaine—Hypoaesthesia—Epirubicin—breast cancer	0.000373	0.000519	CcSEcCtD
Prilocaine—Sweating—Doxorubicin—breast cancer	0.00037	0.000516	CcSEcCtD
Prilocaine—Urticaria—Paclitaxel—breast cancer	0.00037	0.000515	CcSEcCtD
Prilocaine—Hyperhidrosis—Capecitabine—breast cancer	0.00037	0.000515	CcSEcCtD
Prilocaine—Hypotension—Docetaxel—breast cancer	0.000369	0.000514	CcSEcCtD
Prilocaine—Vomiting—Irinotecan—breast cancer	0.000363	0.000506	CcSEcCtD
Prilocaine—Vomiting—Mitoxantrone—breast cancer	0.000363	0.000506	CcSEcCtD
Prilocaine—Dizziness—Fluorouracil—breast cancer	0.000362	0.000504	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PAK1—breast cancer	0.00036	0.00129	CbGpPWpGaD
Prilocaine—Hypotension—Capecitabine—breast cancer	0.000357	0.000498	CcSEcCtD
Prilocaine—Paraesthesia—Docetaxel—breast cancer	0.000355	0.000494	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HSP90AA1—breast cancer	0.000354	0.00128	CbGpPWpGaD
Prilocaine—Vomiting—Gemcitabine—breast cancer	0.000354	0.000493	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—breast cancer	0.000353	0.000492	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—CFL1—breast cancer	0.000352	0.00127	CbGpPWpGaD
Prilocaine—Somnolence—Docetaxel—breast cancer	0.000351	0.000489	CcSEcCtD
Prilocaine—Tinnitus—Epirubicin—breast cancer	0.000349	0.000487	CcSEcCtD
Prilocaine—Vomiting—Fluorouracil—breast cancer	0.000348	0.000484	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PAK1—breast cancer	0.000347	0.00125	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—FGFR1—breast cancer	0.000346	0.00125	CbGpPWpGaD
Prilocaine—Hypoaesthesia—Doxorubicin—breast cancer	0.000345	0.000481	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NCOA1—breast cancer	0.000345	0.00124	CbGpPWpGaD
Prilocaine—Paraesthesia—Capecitabine—breast cancer	0.000343	0.000478	CcSEcCtD
Prilocaine—Hypersensitivity—Paclitaxel—breast cancer	0.000343	0.000478	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—PAK1—breast cancer	0.000342	0.00123	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HSP90AA1—breast cancer	0.000341	0.00123	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ADAM10—breast cancer	0.00034	0.00122	CbGpPWpGaD
Prilocaine—Nausea—Mitoxantrone—breast cancer	0.000339	0.000473	CcSEcCtD
Prilocaine—Nausea—Irinotecan—breast cancer	0.000339	0.000473	CcSEcCtD
Prilocaine—Pain—Docetaxel—breast cancer	0.000338	0.00047	CcSEcCtD
Prilocaine—Arrhythmia—Epirubicin—breast cancer	0.000335	0.000466	CcSEcCtD
Prilocaine—Asthenia—Paclitaxel—breast cancer	0.000334	0.000466	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—MED12—breast cancer	0.000334	0.0012	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—FGFR1—breast cancer	0.000333	0.0012	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCOA1—breast cancer	0.000331	0.00119	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—FGF10—breast cancer	0.000331	0.00119	CbGpPWpGaD
Prilocaine—Nausea—Gemcitabine—breast cancer	0.00033	0.00046	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—breast cancer	0.000329	0.000458	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HSP90AA1—breast cancer	0.000328	0.00118	CbGpPWpGaD
Prilocaine—Pain—Capecitabine—breast cancer	0.000327	0.000455	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—ADAM10—breast cancer	0.000326	0.00118	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KDR—breast cancer	0.000326	0.00118	CbGpPWpGaD
Prilocaine—Feeling abnormal—Docetaxel—breast cancer	0.000325	0.000453	CcSEcCtD
Prilocaine—Nausea—Fluorouracil—breast cancer	0.000325	0.000453	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—HSP90AA1—breast cancer	0.000323	0.00116	CbGpPWpGaD
Prilocaine—Tinnitus—Doxorubicin—breast cancer	0.000323	0.00045	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—breast cancer	0.000322	0.000449	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—FGFR1—breast cancer	0.000321	0.00116	CbGpPWpGaD
Prilocaine—Tension—Epirubicin—breast cancer	0.00032	0.000446	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOA1—breast cancer	0.000319	0.00115	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MET—breast cancer	0.000319	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA3—breast cancer	0.000319	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—WNT1—breast cancer	0.000319	0.00115	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SRC—breast cancer	0.000318	0.00115	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FGF10—breast cancer	0.000318	0.00114	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SLC2A2—breast cancer	0.000317	0.00114	CbGpPWpGaD
Prilocaine—Nervousness—Epirubicin—breast cancer	0.000317	0.000441	CcSEcCtD
Prilocaine—Feeling abnormal—Capecitabine—breast cancer	0.000315	0.000439	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—ADAM10—breast cancer	0.000315	0.00113	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KDR—breast cancer	0.000314	0.00113	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ADAM10—breast cancer	0.00031	0.00112	CbGpPWpGaD
Prilocaine—Arrhythmia—Doxorubicin—breast cancer	0.00031	0.000432	CcSEcCtD
Prilocaine—Dizziness—Paclitaxel—breast cancer	0.000308	0.000429	CcSEcCtD
Prilocaine—Vision blurred—Epirubicin—breast cancer	0.000307	0.000428	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—ABL1—breast cancer	0.000307	0.00111	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MET—breast cancer	0.000307	0.0011	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—FGF10—breast cancer	0.000306	0.0011	CbGpPWpGaD
Prilocaine—Urticaria—Capecitabine—breast cancer	0.000304	0.000423	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—KDR—breast cancer	0.000302	0.00109	CbGpPWpGaD
Prilocaine—Anaemia—Epirubicin—breast cancer	0.000302	0.00042	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SMAD4—breast cancer	0.000298	0.00107	CbGpPWpGaD
Prilocaine—Tension—Doxorubicin—breast cancer	0.000296	0.000413	CcSEcCtD
Prilocaine—Vomiting—Paclitaxel—breast cancer	0.000296	0.000413	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MET—breast cancer	0.000296	0.00107	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ABL1—breast cancer	0.000295	0.00106	CbGpPWpGaD
Prilocaine—Nervousness—Doxorubicin—breast cancer	0.000293	0.000408	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—MAPK3—breast cancer	0.000293	0.00106	CbGpPWpGaD
Prilocaine—Syncope—Epirubicin—breast cancer	0.000293	0.000408	CcSEcCtD
Prilocaine—Hypersensitivity—Docetaxel—breast cancer	0.000291	0.000405	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HES1—breast cancer	0.000291	0.00105	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NCOR1—breast cancer	0.000289	0.00104	CbGpPWpGaD
Prilocaine—Confusional state—Methotrexate—breast cancer	0.000287	0.0004	CcSEcCtD
Prilocaine—Loss of consciousness—Epirubicin—breast cancer	0.000287	0.000399	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SMAD4—breast cancer	0.000286	0.00103	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ABL1—breast cancer	0.000285	0.00103	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Methotrexate—breast cancer	0.000285	0.000396	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—breast cancer	0.000285	0.000396	CcSEcCtD
Prilocaine—Asthenia—Docetaxel—breast cancer	0.000283	0.000395	CcSEcCtD
Prilocaine—Hypertension—Epirubicin—breast cancer	0.000282	0.000392	CcSEcCtD
Prilocaine—Hypersensitivity—Capecitabine—breast cancer	0.000282	0.000392	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—ABL1—breast cancer	0.00028	0.00101	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HES1—breast cancer	0.000279	0.00101	CbGpPWpGaD
Prilocaine—Nervous system disorder—Methotrexate—breast cancer	0.000279	0.000389	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—breast cancer	0.000279	0.000389	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—EGFR—breast cancer	0.000279	0.001	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NCOR1—breast cancer	0.000278	0.001	CbGpPWpGaD
Prilocaine—Anxiety—Epirubicin—breast cancer	0.000277	0.000386	CcSEcCtD
Prilocaine—Nausea—Paclitaxel—breast cancer	0.000277	0.000385	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—SMAD4—breast cancer	0.000276	0.000993	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Methotrexate—breast cancer	0.000275	0.000383	CcSEcCtD
Prilocaine—Asthenia—Capecitabine—breast cancer	0.000274	0.000382	CcSEcCtD
Prilocaine—Syncope—Doxorubicin—breast cancer	0.000271	0.000377	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HES1—breast cancer	0.000269	0.000969	CbGpPWpGaD
Prilocaine—Confusional state—Epirubicin—breast cancer	0.000268	0.000374	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NCOR1—breast cancer	0.000268	0.000964	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA2—breast cancer	0.000266	0.00096	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP2—breast cancer	0.000266	0.000959	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Epirubicin—breast cancer	0.000266	0.000371	CcSEcCtD
Prilocaine—Oedema—Epirubicin—breast cancer	0.000266	0.000371	CcSEcCtD
Prilocaine—Hypotension—Methotrexate—breast cancer	0.000266	0.00037	CcSEcCtD
Prilocaine—Loss of consciousness—Doxorubicin—breast cancer	0.000265	0.00037	CcSEcCtD
Prilocaine—Shock—Epirubicin—breast cancer	0.000262	0.000365	CcSEcCtD
Prilocaine—Nervous system disorder—Epirubicin—breast cancer	0.000261	0.000364	CcSEcCtD
Prilocaine—Dizziness—Docetaxel—breast cancer	0.000261	0.000364	CcSEcCtD
Prilocaine—Hypertension—Doxorubicin—breast cancer	0.000261	0.000363	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—breast cancer	0.000259	0.000932	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Epirubicin—breast cancer	0.000257	0.000359	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—breast cancer	0.000256	0.000357	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MMP2—breast cancer	0.000256	0.000922	CbGpPWpGaD
Prilocaine—Paraesthesia—Methotrexate—breast cancer	0.000256	0.000356	CcSEcCtD
Prilocaine—Somnolence—Methotrexate—breast cancer	0.000253	0.000352	CcSEcCtD
Prilocaine—Dizziness—Capecitabine—breast cancer	0.000253	0.000352	CcSEcCtD
Prilocaine—Vomiting—Docetaxel—breast cancer	0.000251	0.00035	CcSEcCtD
Prilocaine—Hypotension—Epirubicin—breast cancer	0.000249	0.000347	CcSEcCtD
Prilocaine—Confusional state—Doxorubicin—breast cancer	0.000248	0.000346	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL1B—breast cancer	0.000248	0.000894	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—breast cancer	0.000248	0.000892	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—FGFR1—breast cancer	0.000247	0.00089	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP2—breast cancer	0.000247	0.000889	CbGpPWpGaD
Prilocaine—Anaphylactic shock—Doxorubicin—breast cancer	0.000246	0.000343	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—breast cancer	0.000246	0.000343	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PAK1—breast cancer	0.000244	0.000878	CbGpPWpGaD
Prilocaine—Pain—Methotrexate—breast cancer	0.000243	0.000339	CcSEcCtD
Prilocaine—Vomiting—Capecitabine—breast cancer	0.000243	0.000339	CcSEcCtD
Prilocaine—Shock—Doxorubicin—breast cancer	0.000242	0.000338	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—breast cancer	0.000242	0.000337	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—JUN—breast cancer	0.000241	0.000866	CbGpPWpGaD
Prilocaine—Paraesthesia—Epirubicin—breast cancer	0.000239	0.000333	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—breast cancer	0.000239	0.00086	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Doxorubicin—breast cancer	0.000238	0.000332	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—LEP—breast cancer	0.000238	0.000856	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FGFR1—breast cancer	0.000238	0.000855	CbGpPWpGaD
Prilocaine—Somnolence—Epirubicin—breast cancer	0.000237	0.00033	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—RAF1—breast cancer	0.000236	0.00085	CbGpPWpGaD
Prilocaine—Nausea—Docetaxel—breast cancer	0.000235	0.000327	CcSEcCtD
Prilocaine—Feeling abnormal—Methotrexate—breast cancer	0.000234	0.000327	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ERBB2—breast cancer	0.000233	0.000841	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KDR—breast cancer	0.000233	0.000839	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HSP90AA1—breast cancer	0.000231	0.000831	CbGpPWpGaD
Prilocaine—Hypotension—Doxorubicin—breast cancer	0.00023	0.000321	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—FGFR1—breast cancer	0.000229	0.000825	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—LEP—breast cancer	0.000228	0.000822	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MET—breast cancer	0.000228	0.000821	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CDK4—breast cancer	0.000228	0.000821	CbGpPWpGaD
Prilocaine—Pain—Epirubicin—breast cancer	0.000228	0.000317	CcSEcCtD
Prilocaine—Nausea—Capecitabine—breast cancer	0.000227	0.000316	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—RAF1—breast cancer	0.000227	0.000816	CbGpPWpGaD
Prilocaine—Urticaria—Methotrexate—breast cancer	0.000226	0.000315	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—FGFR1—breast cancer	0.000226	0.000813	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOA1—breast cancer	0.000225	0.000809	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—ERBB2—breast cancer	0.000224	0.000808	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KDR—breast cancer	0.000224	0.000806	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ADAM10—breast cancer	0.000221	0.000797	CbGpPWpGaD
Prilocaine—Paraesthesia—Doxorubicin—breast cancer	0.000221	0.000308	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—LEP—breast cancer	0.00022	0.000793	CbGpPWpGaD
Prilocaine—Feeling abnormal—Epirubicin—breast cancer	0.000219	0.000306	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—NOTCH1—breast cancer	0.000219	0.00079	CbGpPWpGaD
Prilocaine—Somnolence—Doxorubicin—breast cancer	0.000219	0.000305	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MET—breast cancer	0.000219	0.000788	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CDK4—breast cancer	0.000219	0.000788	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—RAF1—breast cancer	0.000219	0.000787	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—ERBB2—breast cancer	0.000216	0.000779	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KDR—breast cancer	0.000216	0.000777	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGF10—breast cancer	0.000215	0.000775	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KDR—breast cancer	0.000213	0.000765	CbGpPWpGaD
Prilocaine—Urticaria—Epirubicin—breast cancer	0.000212	0.000295	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MET—breast cancer	0.000211	0.00076	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CDK4—breast cancer	0.000211	0.00076	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NOTCH1—breast cancer	0.000211	0.000759	CbGpPWpGaD
Prilocaine—Pain—Doxorubicin—breast cancer	0.000211	0.000294	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—breast cancer	0.00021	0.000757	CbGpPWpGaD
Prilocaine—Hypersensitivity—Methotrexate—breast cancer	0.00021	0.000292	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—MET—breast cancer	0.000208	0.000749	CbGpPWpGaD
Prilocaine—Asthenia—Methotrexate—breast cancer	0.000204	0.000284	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—NOTCH1—breast cancer	0.000203	0.000732	CbGpPWpGaD
Prilocaine—Feeling abnormal—Doxorubicin—breast cancer	0.000203	0.000283	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MMP9—breast cancer	0.0002	0.000721	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ABL1—breast cancer	0.0002	0.000721	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT2—breast cancer	0.000196	0.000707	CbGpPWpGaD
Prilocaine—Hypersensitivity—Epirubicin—breast cancer	0.000196	0.000273	CcSEcCtD
Prilocaine—Urticaria—Doxorubicin—breast cancer	0.000196	0.000273	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—SMAD4—breast cancer	0.000194	0.000698	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP9—breast cancer	0.000192	0.000693	CbGpPWpGaD
Prilocaine—Asthenia—Epirubicin—breast cancer	0.000191	0.000266	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MMP2—breast cancer	0.00019	0.000685	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HES1—breast cancer	0.000189	0.000681	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT2—breast cancer	0.000189	0.000679	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NCOR1—breast cancer	0.000188	0.000678	CbGpPWpGaD
Prilocaine—Dizziness—Methotrexate—breast cancer	0.000188	0.000262	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MMP9—breast cancer	0.000186	0.000668	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SRC—breast cancer	0.000185	0.000665	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP2—breast cancer	0.000183	0.000658	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT2—breast cancer	0.000182	0.000655	CbGpPWpGaD
Prilocaine—Hypersensitivity—Doxorubicin—breast cancer	0.000182	0.000253	CcSEcCtD
Prilocaine—Vomiting—Methotrexate—breast cancer	0.000181	0.000252	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—TNF—breast cancer	0.00018	0.000648	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—breast cancer	0.00018	0.000647	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SRC—breast cancer	0.000177	0.000639	CbGpPWpGaD
Prilocaine—Asthenia—Doxorubicin—breast cancer	0.000177	0.000246	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MMP2—breast cancer	0.000176	0.000634	CbGpPWpGaD
Prilocaine—Dizziness—Epirubicin—breast cancer	0.000176	0.000245	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—MMP2—breast cancer	0.000174	0.000625	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—breast cancer	0.000173	0.000622	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SRC—breast cancer	0.000171	0.000616	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAPK3—breast cancer	0.00017	0.000612	CbGpPWpGaD
Prilocaine—Vomiting—Epirubicin—breast cancer	0.000169	0.000236	CcSEcCtD
Prilocaine—Nausea—Methotrexate—breast cancer	0.000169	0.000235	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—RAF1—breast cancer	0.000168	0.000606	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RELA—breast cancer	0.000168	0.000604	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ERBB2—breast cancer	0.000167	0.0006	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—breast cancer	0.000167	0.0006	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK3—breast cancer	0.000163	0.000588	CbGpPWpGaD
Prilocaine—Dizziness—Doxorubicin—breast cancer	0.000163	0.000227	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—EGFR—breast cancer	0.000162	0.000583	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RAF1—breast cancer	0.000162	0.000582	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RELA—breast cancer	0.000161	0.00058	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FGFR1—breast cancer	0.000161	0.00058	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ERBB2—breast cancer	0.00016	0.000576	CbGpPWpGaD
Prilocaine—Nausea—Epirubicin—breast cancer	0.000158	0.00022	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MAPK3—breast cancer	0.000158	0.000567	CbGpPWpGaD
Prilocaine—Vomiting—Doxorubicin—breast cancer	0.000157	0.000218	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—RAF1—breast cancer	0.000156	0.000562	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—EGFR—breast cancer	0.000155	0.00056	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RELA—breast cancer	0.000155	0.000559	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—LEP—breast cancer	0.000155	0.000557	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ERBB2—breast cancer	0.000154	0.000556	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RAF1—breast cancer	0.000154	0.000553	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—breast cancer	0.000153	0.00055	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ERBB2—breast cancer	0.000152	0.000547	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KDR—breast cancer	0.000152	0.000546	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—EGFR—breast cancer	0.00015	0.00054	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MET—breast cancer	0.000148	0.000534	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CDK4—breast cancer	0.000148	0.000534	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—breast cancer	0.000147	0.000529	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—breast cancer	0.000146	0.000204	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—CTNNB1—breast cancer	0.000146	0.000525	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL6—breast cancer	0.000145	0.000523	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP9—breast cancer	0.000143	0.000514	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NOTCH1—breast cancer	0.000143	0.000514	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—breast cancer	0.000142	0.00051	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CTNNB1—breast cancer	0.00014	0.000504	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP9—breast cancer	0.000137	0.000494	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CTNNB1—breast cancer	0.000135	0.000486	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP9—breast cancer	0.000132	0.000477	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SRC—breast cancer	0.000132	0.000474	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP9—breast cancer	0.00013	0.00047	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—breast cancer	0.00013	0.000468	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—breast cancer	0.000128	0.000462	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT2—breast cancer	0.000128	0.00046	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—STAT3—breast cancer	0.000127	0.000457	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SRC—breast cancer	0.000127	0.000456	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—breast cancer	0.000125	0.000449	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—IL6—breast cancer	0.000124	0.000448	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP2—breast cancer	0.000124	0.000446	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—breast cancer	0.000123	0.000444	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—STAT3—breast cancer	0.000122	0.000439	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SRC—breast cancer	0.000122	0.000439	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAPK3—breast cancer	0.000121	0.000437	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HRAS—breast cancer	0.00012	0.000433	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SRC—breast cancer	0.00012	0.000433	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—IL6—breast cancer	0.000119	0.00043	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—breast cancer	0.000119	0.000428	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TGFB1—breast cancer	0.000118	0.000424	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—STAT3—breast cancer	0.000118	0.000424	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—breast cancer	0.000117	0.000422	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK3—breast cancer	0.000117	0.00042	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EGFR—breast cancer	0.000115	0.000416	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—IL6—breast cancer	0.000115	0.000415	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TGFB1—breast cancer	0.000113	0.000407	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK3—breast cancer	0.000112	0.000405	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EGFR—breast cancer	0.000111	0.000399	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK3—breast cancer	0.000111	0.000399	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—TNF—breast cancer	0.00011	0.000396	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RAF1—breast cancer	0.00011	0.000395	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RELA—breast cancer	0.000109	0.000393	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TGFB1—breast cancer	0.000109	0.000393	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—breast cancer	0.000109	0.000393	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ERBB2—breast cancer	0.000108	0.000391	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EGFR—breast cancer	0.000107	0.000385	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—TNF—breast cancer	0.000106	0.00038	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EGFR—breast cancer	0.000105	0.000379	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—breast cancer	0.000105	0.000377	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—TNF—breast cancer	0.000102	0.000367	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—breast cancer	0.000101	0.000364	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—breast cancer	9.96e-05	0.000358	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CTNNB1—breast cancer	9.49e-05	0.000342	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP9—breast cancer	9.31e-05	0.000335	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HRAS—breast cancer	9.27e-05	0.000334	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—breast cancer	8.91e-05	0.000321	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—IL6—breast cancer	8.87e-05	0.00032	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—breast cancer	8.59e-05	0.000309	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SRC—breast cancer	8.58e-05	0.000309	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—IL6—breast cancer	8.53e-05	0.000307	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—breast cancer	8.46e-05	0.000305	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—breast cancer	8.36e-05	0.000301	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—STAT3—breast cancer	8.27e-05	0.000298	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—IL6—breast cancer	8.22e-05	0.000296	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—AKT1—breast cancer	8.19e-05	0.000295	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—IL6—breast cancer	8.1e-05	0.000292	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK3—breast cancer	7.91e-05	0.000285	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—AKT1—breast cancer	7.87e-05	0.000283	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TGFB1—breast cancer	7.67e-05	0.000276	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—AKT1—breast cancer	7.58e-05	0.000273	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EGFR—breast cancer	7.52e-05	0.000271	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—TNF—breast cancer	7.16e-05	0.000258	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—breast cancer	7.1e-05	0.000256	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—breast cancer	6.04e-05	0.000217	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—IL6—breast cancer	5.78e-05	0.000208	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—AKT1—breast cancer	5.33e-05	0.000192	CbGpPWpGaD
